A novel oral anaplastic lymphoma kinase inhibitor—lorlatinib

doi:10.3969/j.issn.1672-3384.2019.12.002

PDF(1799 KB)

Clinical Medication Journal ›› 2019, Vol. 17 ›› Issue (12) : 5-6. DOI: 10.3969/j.issn.1672-3384.2019.12.002

A novel oral anaplastic lymphoma kinase inhibitor—lorlatinib

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2019, 17(12): 5-6 https://doi.org/10.3969/j.issn.1672-3384.2019.12.002

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

Funding

RIGHTS & PERMISSIONS

PDF(1799 KB)

Accesses

Citation

Detail

Sections

Recommended

Received	Published
2019-09-30	2019-12-30
Issue Date
2019-12-30

Please choose a citation manager

Content to export